InstalabLoading...
InstalabLoading...
When you get a coronary calcium scan, the radiologist does not just hand you a single total number. The scan breaks calcified plaque down by individual artery, and this score reports how much hardened plaque sits in the posterior descending artery, a vessel that runs along the back of your heart and supplies blood to a large portion of the lower wall and the heart's electrical system. Knowing where your plaque lives, not just how much you have, gives you a more precise read on where atherosclerosis is taking hold.
This is a per-vessel breakdown of the broader coronary artery calcium (CAC) score, a test that has become one of the most reliable predictors of heart attack and cardiovascular death in people without symptoms. Most published research reports the total CAC score rather than a vessel-specific number, so the PDA component is best used as part of the full per-vessel picture alongside the left main, left anterior descending, circumflex, and right coronary scores.
PDA stands for posterior descending artery. In most people, it branches off the right coronary artery, and in a smaller share, it branches off the circumflex. The test counts how much calcium has accumulated inside that specific vessel, reported in Agatston units. Calcified plaque forms when long-running irritation of the artery wall triggers smooth muscle cells to behave like bone-building cells, depositing calcium into the plaque. The score reflects how long, and how aggressively, that process has been happening in this particular artery.
A higher number in the posterior descending artery means more hardened plaque sits there. A score of zero means the scan did not detect any calcified plaque in that vessel, though it does not rule out softer, non-calcified plaque that calcium scoring cannot see.
The overwhelming majority of evidence linking coronary calcium to outcomes uses the total score across all arteries. In a meta-analysis of about 34,000 symptomatic patients, higher total calcium scores were strongly tied to a higher rate of major heart events. In an analysis of 6,814 adults followed for ten years through the Multi-Ethnic Study of Atherosclerosis, total CAC strongly predicted heart attack and cardiovascular death regardless of age, sex, or ethnicity.
Your PDA score contributes to that total. A high PDA score with low scores elsewhere tells a different story than calcium spread evenly across every vessel. Research has not produced standardized cutpoints for individual artery scores, so the PDA reading is most useful as one piece of the full breakdown, not a number to interpret in isolation.
Studies on total CAC, which includes the PDA component, give the clearest read on risk. In a study of 4,948 adults in the multinational CONFIRM registry, people with a total CAC score above 300 had a rate of major heart events similar to people who had already been diagnosed with cardiovascular disease. In a follow-up of 66,636 asymptomatic adults from the CAC Consortium, those with total scores of 1,000 or higher had substantially elevated risk of cardiovascular death, cancer death, and death from any cause compared with people in the 400 to 999 range.
In younger adults, the story is similar. A study of 13,397 adults under 50 found that any detectable coronary calcium raised long-term risk of heart attack and stroke, and severe calcification pushed risk of death noticeably higher. These findings come from total CAC, not the posterior descending artery score specifically, but the PDA contributes to the total.
A retrospective study of 4,529 adults linked higher total CAC scores to higher rates of death from any cause, an association that was especially strong in people under 65. A systematic review combining low-dose CT lung cancer screening data also found that incidentally detected coronary calcium predicted cardiovascular death in current and former smokers.
Calcium in the coronary arteries is not only a downstream marker of heart disease. In a study of 113,171 younger and middle-aged adults, higher total CAC scores predicted future chronic kidney disease, even at low calcium levels. In 1,579 adults already living with chronic kidney disease (the KNOW-CKD cohort), total CAC independently predicted heart events and death.
There are no standardized clinical cutpoints for the posterior descending artery score on its own. The ranges below come from the broader CAC literature, which reports total scores across all arteries. Use these as orientation for understanding the magnitude of your PDA number in the context of your total score, not as targets specific to one vessel. Your radiologist's report will compare your numbers across vessels and against age, sex, and sometimes ethnicity-specific percentiles.
| Total CAC Tier | Agatston Score | What It Suggests |
|---|---|---|
| Zero | 0 | No detectable calcified plaque, very low short-term event risk in asymptomatic adults |
| Mild | 1 to 99 | Some atherosclerosis present, modestly elevated risk that warrants attention to standard risk factors |
| Moderate | 100 to 299 | Substantial plaque burden, risk comparable to needing primary prevention therapy in most cases |
| High | 300 or higher | Risk approaching that of people with established cardiovascular disease per CONFIRM registry analysis |
These tiers are drawn from total CAC literature, not the posterior descending artery score specifically. Lab-to-lab variation in CT protocols can shift individual numbers, so the most useful comparisons happen within the same scanner and the same reading method over time.
A single calcium scan is a snapshot. Calcified plaque does not disappear, so a once-and-done view of your PDA score tells you what has built up over decades, not what is happening now. The more useful question is whether your number is growing slowly, holding steady relative to age expectations, or progressing fast. Repeated CT scans show how plaque is moving and whether your prevention plan is keeping pace.
Interscan variability is real. A classic study of 120 patients found that repeated electron-beam CT measurements varied by about 19.9 percent using traditional Agatston scoring. Treat changes smaller than roughly 15 to 20 percent with caution, especially for low absolute scores where a small absolute change can look like a big percent change.
A reasonable cadence: get a baseline scan, repeat in 3 to 5 years if you are actively managing risk factors and starting from a low or moderate score, and sooner if you are starting therapy and want to gauge response. Radiation exposure is low but not zero, so you do not want to repeat every year without reason.
A few situations can distort a single reading or change how you should interpret it:
Statins increase calcium scores but reduce heart attacks, which sounds like a contradiction. The resolution: not all plaque carries equal risk. Soft, non-calcified plaque is more likely to rupture and cause a heart attack. Statins appear to push soft plaque toward a denser, more stable, calcified form. So a rising calcium number on statins, in the posterior descending artery or elsewhere, can reflect plaque stabilization rather than disease progression. This is why doctors interpret serial CAC scores differently in people on statins than in people who are not.
An elevated number in the posterior descending artery, especially alongside elevated scores in other vessels, is a signal to act on cardiovascular risk factors aggressively. Concrete next steps:
A high CAC score is one of the strongest signals that intensive prevention is worth the effort. A meta-analysis of intervention studies found that a non-zero score significantly raises the likelihood that people start and stay on statins, aspirin, and lifestyle changes. The number is most useful when it changes what you do.
Evidence-backed interventions that affect your CAC Score PDA level
CAC Score PDA is best interpreted alongside these tests.